[Federal Register Volume 68, Number 246 (Tuesday, December 23, 2003)]
[Notices]
[Pages 74275-74276]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-31547]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application of Bio-Imaging 
Technologies, Inc. To Withdraw Its Common Stock, $.00025 Par Value, 
From Listing and Registration on the American Stock Exchange LLC File 
No. 1-11182

December 17, 2003.
    Bio-Imaging Technologies, Inc., a Delaware corporation 
(``Issuer''), has filed an application with the Securities and Exchange 
Commission (``Commission''), pursuant to section 12(d) of the 
Securities Exchange Act of 1934 (``Act'')\1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its common stock, $.00025 par value 
(``Security''), from listing and registration on the American Stock 
Exchange LLC (``Amex'' or ``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Board of Directors (``Board'') of the Issuer unanimously 
approved a resolution on November 5, 2003 to withdraw the Issuer's 
Security from listing on the Amex and to list the Security on the 
Nasdaq National Market System (``Nasdaq NMS''). The Board states that 
it is taking such action because the Board believes that listing on the 
Nasdaq NMS will provide additional liquidity to the Issuer's 
stockholders and provide additional benefits to the Issuer and its 
stockholders such as, among other things, greater coverage by analysts 
and greater interest by institutional investors.
    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
Delaware, in which it is incorporated, and with the Amex's rules 
governing an issuer's voluntary withdrawal of a security from listing 
and registration.
    The Issuer's application relates solely to the withdrawal of the 
Securities from listing on the Amex and from registration under section 
12(b) of the Act \3\ and shall not affect its obligation

[[Page 74276]]

to be registered under section 12(g) of the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before January 9, 2004, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Amex and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Jonathan G. Katz,
Secretary.
[FR Doc. 03-31547 Filed 12-22-03; 8:45 am]
BILLING CODE 8010-01-P